320
Participants
Start Date
April 1, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2028
TURBT
Transurethral Resection of Bladder Tumors
HIVEC
Hyperthermic Intravesical Chemotherapy with Gemcitabine (3g/150ml NS) at 45 °C for 60 minutes. Induction perfusion was required to start within 4 weeks, once a week (±5 days) for 6 to 8 times. After the last induction infusion, maintenance infusion was performed, once every month (±2 weeks) for 1 year from the first induction infusion.
Intravesical Chemotherapy
Intravesical Chemotherapy with Gemcitabine (3g/150ml NS). Induction perfusion was required to start within 4 weeks, once a week (±5 days) for 6 to 8 times. After the last induction infusion, maintenance infusion was performed, once every month (±2 weeks) for 1 year from the first induction infusion.
Gemcitabine
Gemcitabine (3g/150ml NS).
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER